GLP-1 medications like Semaglutide (found in Ozempic and Wegovy) and Tirzepatide (found in Mounjaro) mimic the body’s natural ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...

A popular brand of eye drops is being recalled nationwide after a consumer reported a "foreign material" was found in a ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

UNITED STATES - A new generic treatment option for people with type 2 diabetes has been approved by the FDA. The generic ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Duquesne Family Office's chief is cashing in his chips on two leading artificial intelligence (AI) stocks in favor of a ...

“This bipartisan legislation will promote generic drug competition and improve patient access to lower-cost medications,” said Senator Collins. “By reaffirming the so-called ‘skinny label’ pathway, ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...